The Clinical
Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic
Fatty Liver Disease and Hepatitis C Virus
Ikarashi Y, Kodama K, Taniai M, et al
Intern Med. 2017 Dec 21
Abstract
Statins and risk of decompensation in hepatitis B virus- and hepatitis C
virus-related cirrhosis: Methodological issues.
Lin CY.
Hepatology.
2017 Nov 24.
Abstract
FULL-TEXT ARTICLE
Antiviral therapies for chronic hepatitis C virus infection with cirrhosis.
Nakamoto S, Kanda T, Shirasawa H, Yokosuka O.
World J
Hepatol. 2015 May
18;7(8):1133-41
Paper
Effect of Viral Suppression on Hepatic Venous Pressure
Gradient in Hepatitis C With Cirrhosis and Portal Hypertension.
Afdhal N, Everson GT, Calleja JL, et al
J Viral Hepat.
2017 Mar 10.
Abstract
Treatment of hepatitis C virus infection in patients with cirrhosis and
predictive value of MELD: Analysis of data from the Hepa-C registry.
Fernández Carrillo C, Lens S, Llop E,
et al
Hepatology. 2017 Feb 7.
Abstract
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis
treated with ribavirin-containing interferon-free regimens.
Coppola N, De Pascalis S, Messina V, et al
Antivir Ther. 2017 Feb 6.
Abstract
Week 4-response predicts sustained virologic response to
all-oral direct-acting antiviral-based therapy in cirrhotic patients with
hepatitis C virus genotype 3 infection.
Pineda JA, Morano-Amado LE, Granados R,
et al
Clin Microbiol Infect.
2017 Jan 27.
.
Abstract
Evaluation of coagulation during treatment with directly acting antivirals
in patients with hepatitis C virus related cirrhosis.
Tripodi A, D'Ambrosio R, Padovan L,
Liver Int.
2017 Jan 2
Abstract
Prognosis of 1169 hepatitis C chronically infected patients with
decompensated cirrhosis in the predirect-acting antiviral era.
McDonald SA, Innes HA,
Aspinall E, et
a;
J Viral Hepat.
2016 Nov 25.
Abstract
Therapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver
Cirrhosis.
Toshikuni N.
Gut Liver. 2016 Nov 14.
Abstract
Risk of cirrhosis-related complications in patients with advanced fibrosis
following hepatitis C virus eradication.
van der Meer AJ, Feld JJ, et al
J Hepatol.
2016 Oct 22. .
Abstract
Predictors of hospital re-admissions among Hispanics with hepatitis
C-related cirrhosis.
Atla PR, Sheikh MY, Gill F, Kundu R, Choudhury J.
Ann Gastroenterol.
2016 Oct-Dec;29(4):515-520.
Abstract
Th2 Dominance Might Induce Carcinogenesis in Patients with HCV-related
Liver Cirrhosis.
Kogame M, Nagai H, Shinohara
M, et ak
Anticancer Res. 2016
Sep;36(9):4529-36.
Abstract
Hepatitis C Virus Infection Is Positively Associated with Gallstones in
Liver Cirrhosis.
Zhang FM, Chen LH, Chen HT, et al
Digestion.
2016 Apr 19;93(3):221-228.
Abstract
Treat chronic hepatitis C virus infection in decompensated cirrhosis - pre-
or post-liver transplantation? the ironic conundrum in the era of effective
and well-tolerated therapy.
Bunchorntavakul C, Reddy KR.
J Viral Hepat. 2016 Mar
28..
Abstract
Improvement of renal dysfunction in a patient with HCV-related liver
cirrhosis by daclatasvir and asunaprevir combination therapy: A case report.
Tsuge M, Hiramatsu A, Shinohara F, et al
Hepatol Res. 2015 Nov
27
Abstract
FULL-TEXT ARTICLE
Sofosbuvir and
Velpatasvir for HCV in Patients with Decompensated Cirrhosis.
Curry MP, O'Leary JG, Bzowej N, et al
N Engl J Med.
2015 Nov 16
Paper
Relationship of hepatic fibrosis, cirrhosis, and mortality
with cholecystectomy in patients with hepatitis C virus infection.
Martin DJ, Weideman R, Crook T, Brown G.
Eur J Gastroenterol Hepatol.
2015 Nov 12..
Abstract
FULL-TEXT ARTICLE
Direct antiviral agent treatment of decompensated hepatitis C
virus-induced liver cirrhosis.
Ohkoshi S, Hirono
H, Yamagiwa S.
World J Gastrointest Pharmacol Ther.
2015 Nov 6;6(4):114-9.
Paper
Strategies for treating chronic HCV infection in patients
with cirrhosis: latest evidence and clinical outcomes.
Wilder JM, Muir AJ.
Ther Adv Chronic Dis. 2015 Nov;6(6):314-27
Abstract
Sustained Virologic Response of 100% in HCV Genotype 1b Patients with
Cirrhosis Receiving Ombitasvir/Paritaprevir/r and Dasabuvir for 12 Weeks.
Feld JJ, Moreno C, Trinh R, Tam E, et al
J Hepatol. 2015 Oct 14.
Abstract
Altered metal metabolism in patients with HCV-related
cirrhosis and hepatic encephalopathy.
Marano M, Vespasiani Gentilucci U
et al
Metab Brain Dis. 2015 Aug 27.
Abstract
Statin use and the risk of cirrhosis development in patients
with hepatitis C virus infection.
Yang YH, Chen WC, Tsan YT,
et al
Hepatol.
2015 Jul 18.
.
Abstract
Antiviral Therapy in Patients with Hepatitis C Virus-Induced
Cirrhosis.
Bailly F, Pradat P,
Virlogeux V, Zoulim F.
Dig Dis.
2015;33(4):613-623.
Abstract
Successful and Safe Long-Term Standard Antiviral Therapy in a
Patient with "Explosive" Immune Response in Course of HCV-Related Liver
Cirrhosis.
Conca P, Cafaro G,
De Renzo A,
et al
Int J Mol Sci.
2015 Jun 19;16(6):14075-14085
Abstract
HCV targeting of patients with cirrhosis.
Ferenci P, Kozbial K, Mandorfer M,
Hofer H.
J Hepatol. 2015 Jun 19.
Abstract
Treatment of Hepatitis C in Patients with Cirrhosis:
Remaining
Challenges for Direct-Acting Antiviral Therapy.
Majumdar A, Kitson MT, Roberts SK.
Drugs. 2015 May 6.
Abstract
Sorting out cirrhosis: Mechanisms of non-response to
hepatitis C therapy.
Al Marzooqi SH, Feld JJ.
Liver Int. 2015 May
2.
Abstract
Management of HCV in Cirrhosis-a Rapidly Evolving Landscape.
Sharma SA, Feld JJ.
Curr Gastroenterol Rep.
2015 May;17(5):443..
Abstract
Cirrhotic patients are still at risk of developing
hepatocellular carcinoma despite Interferon-induced sustained virological
response.
Pinzone MR, Zanghì
AM, Rapisarda L, et al
Eur Rev Med Pharmacol Sci.
2014 Dec;18(2 Suppl):11-5.
Abstract
Prognostic gene signature profiles of hepatitis C-related
early-stage liver cirrhosis.
Venkatesh A, Sun X, Hoshida
Y.
Genom Data.
2014 Dec 1;2:361-362.
Abstract
A genomic and clinical prognostic index for hepatitis
C-related early-stage cirrhosis that predicts clinical deterioration.
King LY, Canasto-Chibuque C, Johnson KB, et al.
Gut.
2014 Aug 20..
Abstract
HCV cirrhosis at the edge of decompensation: Will ABT-450/r,
ombitasvir, dasabuvir and ribavirin solve the need for treatment?
Asselah T, Bruno S, Craxi A.
J Hepatol. 2014 Aug 19..
Abstract
Increased risk of cirrhosis and its decompensation in chronic
hepatitis C patients with new onset diabetes: A nationwide cohort study.
Huang YW, Yang SS, Fu SC, et
al
Hepatology. 2014 Jun 11..
Abstract
Prevention of Disease Progression with Anti-Inflammatory Therapy in Patients
with HCV-Related Cirrhosis: A Markov Model.
Ikeda K, Kawamura Y, Kobayashi M,
et al
Oncology.
2014 Jun 7;86(5-6):295-302.
Abstract
ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with
Cirrhosis.
Poordad F, Hezode C, Trinh R, et al
N Engl J Med.
2014 Apr 11
Abstract
Patient-reported outcomes in chronic hepatitis C patients with cirrhosis
treated with sofosbuvir-containing regimens.
Younossi ZM, Stepanova M, Nader F, et al
Hepatology. 2014 Apr 8.
Abstract
FULL-TEXT ARTICLE
Hepatitis
C-related liver cirrhosis - strategies for the prevention of hepatic
decompensation, hepatocarcinogenesis, and mortality.
Toshikuni N, Arisawa T, Tsutsumi M.
World J Gastroenterol.
2014 Mar 21;20(11):2876-2887.
Paper
FULL-TEXT ARTICLE
Skin Adverse
Events During Dual and Triple Therapy for HCV-Related Cirrhosis.
Federico A, Sgambato D, Cotticelli G,
Hepat Mon.
2014 Mar 11;14(3):e16632.
Paper
Spleen stiffness measurement can predict clinical complications
in compensated HCV-related cirrhosis: a prospective study.
Colecchia A, Colli A, Casazza G, et al
J Hepatol. 2014 Mar 6.
Abstract
Diabetes worsening of hepatitis C cirrhosis: Are alterations in monocytic
tissue factor (CD 142) is the cause?
El
Makarem MA, Eslam M, Sayed D, et al
Ann
Hepatol. 2013 Jan-2014
Feb;13(1):27-37
Abstract
Treatment of decompensated cirrhosis secondary to hepatitis C
with antiviral therapy.
Khokhar N, Qureshi MO, Niazi
TK.
J Coll Physicians Surg Pak.
2013 Dec;23(12):833-6..
Abstract
Prediction of liver complications in patients with
HCV-related cirrhosis with and without HIV coinfection: comparison of
hepatic venous pressure gradient and transient elastography.
Pérez-Latorre L, Sánchez-Conde M,
Rincón D, et al
Clin Infect Dis.
2013 Nov 21.
Abstract
Liver stiffness measurement by acoustic radiation force
impulse is useful in predicting the presence of esophageal varices or
high-risk esophageal varices among patients with HCV-related cirrhosis.
Morishita N, Hiramatsu N,
Oze T,
et al
J
Gastroenterol. 2013 Sep 5.
Abstract
Splenectomy prior to antiviral therapy in patients with
hepatitis C virus related decompensated cirrhosis.
Ji F, Zhang S, Huang N,
et al
Braz J Infect Dis. 2013
Jul 2
Abstract
FULL-TEXT ARTICLE
Treatment of
hepatitis C in compensated cirrhotic patients is equally effective before and
after liver transplantation.
Ponziani FR, Annicchiarico EB, Siciliano M, et al
World J Gastroenterol. 2013
Jun 7;
Paper
Oral supplementation with branched-chain amino acid granules
prevents hepatocarcinogenesis in patients with hepatitis C-related cirrhosis: a
propensity score analysis.
Tada T, Kumada T, Toyoda H,
et al
Hepatol Res. 2013 Mar
29. .
Abstract |
HCV
Main Page
Documents
identified with this icon are in Portable Document Format (PDF) and require
the
Adobe Acrobat
Reader
